Page last updated: 2024-10-25

diazoxide and Neurodevelopmental Disorders

diazoxide has been researched along with Neurodevelopmental Disorders in 2 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Rasmussen, AG1
Melikian, M1
Globa, E1
Detlefsen, S1
Rasmussen, L1
Petersen, H1
Brusgaard, K1
Rasmussen, AH1
Mortensen, MB1
Christesen, HT1
Laimon, W1
Aboelenin, HM1
El Tantawi, NT1

Other Studies

2 other studies available for diazoxide and Neurodevelopmental Disorders

ArticleYear
The difficult management of persistent, non-focal congenital hyperinsulinism: A retrospective review from a single, tertiary center.
    Pediatric diabetes, 2020, Volume: 21, Issue:3

    Topics: Adolescent; Adult; Child; Child, Preschool; Cohort Studies; Congenital Hyperinsulinism; Denmark; Dia

2020
Clinical characteristics, outcome, and predictors of neurological sequelae of persistent congenital hyperinsulinism: A single tertiary center experience.
    Pediatric diabetes, 2021, Volume: 22, Issue:3

    Topics: Adolescent; Brain; Child; Child, Preschool; Cohort Studies; Congenital Hyperinsulinism; Diazoxide; E

2021